Biotech & Commercialization

This track explores the translation of early laboratory innovations into scalable, market-ready therapeutic products. Topics include venture capital funding, scalable scale-up manufacturing, and intellectual property protection strategies. Entrepreneurs at Stem Cells 2027 will share successfully commercialized case models. Attendees will master biotech business translation and cellular product scale-up pathways.

Related Conference of Immunology